On Tuesday, January 21, 2025, the Garden State officially opened the registration process for its State Price Transparency Reporting (SPTR) program. This means that drug manufacturers who meet the reporting criteria must now register with the Drug Affordability Unity at the NJ Division of Consumer Affairs and prepare to comply with the state's drug price transparency requirements.
All reporting entities - including drug manufacturers - have a short window to register; registration is required by January 31, 2025. To register, manufacturers must use the Excel spreadsheet template provided. For additional guidance, you may refer to the Data Collection Manual. While not explicitly stated in the Manual, it appears that the "entity type" for drug manufacturers should be: "Manufacturer." Moreover, it appears that completed registration forms should be emailed to: [email protected]. As a reminder, in NJ, reporting of applicable price increases and new drugs already went into effect on August 1, 2024. To visit the NJ registration page for more info, please see here.
0 Comments
Leave a Reply. |
Categories |